                         SEQUENCE LISTING

<110>  AMBERSTONE BIOSCIENCES, INC.
       Wu, Guikai
       SHANG, Yonglei
 
<120>  COMPARTMENTALIZED ASSAYS OF BISPECIFIC AND MULTISPECIFIC 
       BIOLOGICS

<130>  AMBR.003WO

<140>  PCT/US2019/055047
<141>  2019-10-07

<150>  67,742/837
<151>  2018-10-08

<150>  67/784,171
<151>  2018-12-21

<160>  42    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  1

Gly Gly Gly Ser 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  2

Gly Gly Ser Gly 
1               


<210>  3
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker peptide

<400>  3

Gly Gly Gly Gly Ser 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  4

Gly Gly Ser Gly Gly 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  5

Gly Lys Pro Gly Ser 
1               5   


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  6

Gly Lys Pro Gly Gly Ser 
1               5       


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  7

Gly Lys Pro Gly Gly Gly Ser 
1               5           


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide


<220>
<221>  REPEAT
<222>  (2)..(2)
<223>  Xaa is (Glu Ala Ala Ala Lys)

<220>
<221>  REPEAT
<222>  (3)..(3)
<223>  Xaa is (Glu Ala Ala Ala Lys)n, where n is 0 to 7

<400>  8

Ala Xaa Xaa Ala 
1               


<210>  9
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide


<220>
<221>  REPEAT
<222>  (2)..(2)
<223>  Xaa is (Ala Ala Ala Ala Thr)n, where n is between 1 and 8

<400>  9

Thr Xaa Ala Ala Ala 
1               5   


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  10

Phe Asn Arg Gly Glu Cys 
1               5       


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  11

Glu Pro Ser Gly Pro 
1               5   


<210>  12
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  12

Leu Gly Gly Cys 
1               


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  13

Val Glu Pro Lys Glu Cys 
1               5       


<210>  14
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  14

Pro Ser Gly Gln Ala Gly Ala Ala Ala Ser Glu Ser Leu Phe Val Ser 
1               5                   10                  15      


Asn His Ala Tyr 
            20  


<210>  15
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  15

Ala Lys Thr Thr Pro Lys Leu Glu Glu Gly Glu Phe Ser Glu Ala Arg 
1               5                   10                  15      


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  16

Ala Lys Thr Thr Pro Lys Leu Glu Glu Gly Glu Phe Ser Glu Ala Arg 
1               5                   10                  15      


Val 
    


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  17

Ala Lys Thr Thr Pro Lys Leu Gly Gly 
1               5                   


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  18

Ser Ala Lys Thr Thr Pro Lys Leu Gly Gly 
1               5                   10  


<210>  19
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  19

Ala Lys Thr Thr Pro Lys Leu Glu Glu Gly Glu Phe Ser Glu Ala Arg 
1               5                   10                  15      


Val 
    


<210>  20
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  20

Ser Ala Lys Thr Thr Pro 
1               5       


<210>  21
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  21

Ser Ala Lys Thr Thr Pro Lys Leu Gly Gly 
1               5                   10  


<210>  22
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  22

Arg Ala Asp Ala Ala Pro 
1               5       


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  23

Arg Ala Asp Ala Ala Pro Thr Val Ser 
1               5                   


<210>  24
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  24

Arg Ala Asp Ala Ala Ala Ala Gly Gly Pro Gly Ser 
1               5                   10          


<210>  25
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide


<220>
<221>  REPEAT
<222>  (8)..(8)
<223>  Xaa is (Gly Gly Gly Gly Ser)n, where n is 1 to 3

<400>  25

Arg Ala Asp Ala Ala Ala Ala Xaa 
1               5               


<210>  26
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  26

Ser Ala Lys Thr Thr Pro Lys Leu Glu Glu Gly Glu Phe Ser Glu Ala 
1               5                   10                  15      


Arg Val 
        


<210>  27
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  27

Ala Asp Ala Ala Pro 
1               5   


<210>  28
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  28

Ala Asp Ala Ala Pro Thr Val Ser Ile Phe Pro Pro 
1               5                   10          


<210>  29
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  29

Thr Val Ala Ala Pro 
1               5   


<210>  30
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  30

Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro 
1               5                   10          


<210>  31
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  31

Gln Pro Lys Ala Ala Pro 
1               5       


<210>  32
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  32

Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro 
1               5                   10              


<210>  33
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  33

Ala Lys Thr Thr Pro Pro 
1               5       


<210>  34
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  34

Ala Lys Thr Thr Pro Pro Ser Val Thr Pro Leu Ala Pro 
1               5                   10              


<210>  35
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  35

Ala Lys Thr Thr Ala Pro 
1               5       


<210>  36
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  36

Ala Lys Thr Thr Ala Pro Ser Val Tyr Pro Leu Ala Pro 
1               5                   10              


<210>  37
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  37

Gly Pro Ala Lys Glu Leu Thr Pro Leu Lys Glu Ala Lys Val Ser 
1               5                   10                  15  


<210>  38
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  38

Ala Ser Thr Lys Gly Pro 
1               5       


<210>  39
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  39

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro 
1               5                   10              


<210>  40
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  40

Gly Glu Asn Lys Val Glu Tyr Ala Pro Ala Leu Met Ala Leu Ser 
1               5                   10                  15  


<210>  41
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  41

Gly His Glu Ala Ala Ala Val Met Gln Val Gln Tyr Pro Ala Ser 
1               5                   10                  15  


<210>  42
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker peptide

<400>  42

Val Glu Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
1               5                   10                  15      


Val Asp 
        


